Seunghoon Han - Search Results

Year	Number of Results
2004	2
2005	2
2006	1
2007	2
2008	1
2009	1
2010	1
2011	5
2012	5
2013	7
2014	6
2015	10
2016	13
2017	10
2018	7
2019	7
2020	6
2021	4
2022	6
2023	7
2024	3

1

Han S. Han S. Clin Exp Vaccine Res. 2015 Jan;4(1):46-53. doi: 10.7774/cevr.2015.4.1.46. Epub 2015 Jan 30. Clin Exp Vaccine Res. 2015. PMID: 25648742 Free PMC article. Review.

2

Alcohol Use and Firearm Violence.

Branas CC, Han S, Wiebe DJ. Branas CC, et al. Among authors: han s. Epidemiol Rev. 2016;38(1):32-45. doi: 10.1093/epirev/mxv010. Epub 2016 Jan 24. Epidemiol Rev. 2016. PMID: 26811427 Free PMC article. Review.

3

Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans.

Bae SH, Park WS, Han S, Park GJ, Lee J, Hong T, Jeon S, Yim DS. Bae SH, et al. Among authors: han s. Biopharm Drug Dispos. 2017 Jul;38(5):363. doi: 10.1002/bdd.2060. Epub 2017 Feb 6. Biopharm Drug Dispos. 2017. PMID: 28027398

4

Establishing Rationale for the Clinical Development of Cell Therapy Products: Consensus between Risk and Benefit.

Han S, Yim HW, Jeong H, Choi S, Han S. Han S, et al. Int J Stem Cells. 2023 Feb 28;16(1):16-26. doi: 10.15283/ijsc21189. Epub 2022 Dec 31. Int J Stem Cells. 2023. PMID: 36581365 Free PMC article. Review.

5

Gate-Tunable Conducting Oxide Metasurfaces.

Huang YW, Lee HW, Sokhoyan R, Pala RA, Thyagarajan K, Han S, Tsai DP, Atwater HA. Huang YW, et al. Among authors: han s. Nano Lett. 2016 Sep 14;16(9):5319-25. doi: 10.1021/acs.nanolett.6b00555. Epub 2016 Sep 2. Nano Lett. 2016. PMID: 27564012

6

A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519.

Kim CO, Jeon S, Han S, Park MS, Yim DS. Kim CO, et al. Among authors: han s. Pharmaceutics. 2020 Jun 19;12(6):573. doi: 10.3390/pharmaceutics12060573. Pharmaceutics. 2020. PMID: 32575566 Free PMC article.

7

Printable Nanocomposite Metalens for High-Contrast Near-Infrared Imaging.

Yoon G, Kim K, Kim SU, Han S, Lee H, Rho J. Yoon G, et al. Among authors: han s. ACS Nano. 2021 Jan 26;15(1):698-706. doi: 10.1021/acsnano.0c06968. Epub 2021 Jan 1. ACS Nano. 2021. PMID: 33385188

8

Metabolic Disease Incidence After Allogeneic Stem Cell Transplantation: A Nationwide Korean Case-Control Study.

Ha J, Park SH, Park SS, Han S. Ha J, et al. Among authors: han s. J Clin Endocrinol Metab. 2022 Mar 24;107(4):943-952. doi: 10.1210/clinem/dgab900. J Clin Endocrinol Metab. 2022. PMID: 34905058

9

Risk of secondary nonhematologic malignancies after allogeneic stem cell transplantation: A nationwide case-control cohort study.

Park SS, Park SH, Han S. Park SS, et al. Among authors: han s. Int J Cancer. 2022 Oct 1;151(7):1024-1032. doi: 10.1002/ijc.34115. Epub 2022 Jun 11. Int J Cancer. 2022. PMID: 35554932 Free article.

10

A Bayesian Analysis of a Cognitive-Behavioral Therapy Intervention for High-Risk People on Probation.

Han S, Hyatt JM, Barnes GC, Sherman LW. Han S, et al. Eval Rev. 2023 Dec 7:193841X231203737. doi: 10.1177/0193841X231203737. Online ahead of print. Eval Rev. 2023. PMID: 38062749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year